Akamatsu H, Nishikawa T, Takeda Y, Misumi T, et al. Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies. Lung Cancer 2025;201:108437.
PMID: 39938189